mTOR signaling as a driver of Castleman disease

Blood. 2020 May 7;135(19):1614-1615. doi: 10.1182/blood.2020005361.
No abstract available

Publication types

  • Comment

MeSH terms

  • Castleman Disease*
  • Humans
  • Signal Transduction
  • TOR Serine-Threonine Kinases

Substances

  • MTOR protein, human
  • TOR Serine-Threonine Kinases